Vilon (Lys-Glu) — Research Peptide Bulk Supply
Also known as: Lysylglutamic acid, Lysylglutamate, KE dipeptide, Dipeptide bioregulator KE
Vilon (L-Lys-L-Glu) is a Khavinson thymic dipeptide bioregulator studied for T-cell differentiation and NF-κB gene regulation. >99% purity.
Khavinson short-peptide bioregulators are listed for catalog and chromatin / gene-expression research framing only. PeptideDistro.com makes no clinical, dosage, or treatment claims.
Bulk Catalog Specifications
- Lyophilized powder
- Purity: >99% by HPLC
- Available research vial sizes: 10 mg, 20 mg
- Storage: -20°C, protect from light
- Solubility: Soluble in water
- COA with HPLC and mass spectrometry data provided per lot
- Cold-chain shipping documentation available
- Private-label and white-label bulk inquiry form available
Scientific Identifiers
| Sequence | L-Lys-L-Glu (dipeptide) |
|---|---|
| Residue count | 2 |
| Molecular formula | C11H21N3O5 |
| Molecular weight | 275.30 g/mol |
| PubChem CID | TBD — search PubChem |
Research Mechanism Summary
Vilon (L-Lys-L-Glu) is a synthetic dipeptide bioregulator originally isolated from bovine thymalin by Khavinson et al. It operates epigenetically, selectively binding the CHUK gene (encoding an NF-κB pathway kinase) and modulating chromatin accessibility through deheterochromatinization of facultative heterochromatin—reactivating ribosomal RNA genes and promoting protein synthesis in aging immune cells. In irradiation models, Vilon stimulated thymocyte proliferating cell nuclear antigen (PCNA) index from 26% to 37% and supported recovery of thymic cortex architecture. Studies report up to 6-fold reduction in inflammatory cytokine synthesis alongside increased IL-2 expression and CD4/CD5 upregulation on thymic cells, indicating T-helper cell differentiation (https://www.seekpeptides.com/blog/articles/vilon-peptide-benefits). The dipeptide shows longevity-relevant data: in female rats given subcutaneous injections 5×/week for 12 months, maximum lifespan of the 10% longest-lived controls was extended from 949 to 1048 days and tumor incidence was 1.5-fold lower (https://pubmed.ncbi.nlm.nih.gov/11707921/).
For Research Use Only. Not for human or veterinary use. Page copy reflects published preclinical and biochemistry literature only and does not constitute dosage, administration, treatment, or therapeutic guidance.
Catalog Context
Vilon (Lys-Glu) is supplied as a research-grade lyophilized peptide catalog item under the Peptide Bioregulators (Khavinson) family. PeptideDistro.com lists this entry for qualified research and wholesale buyers; pricing, MOQ, and documentation packets are reviewed during account intake. Page copy is framed exclusively around mechanism literature, molecular identifiers, and bulk catalog specifications.
Frequently Studied Together
Wholesale & Documentation
PeptideDistro.com supplies Vilon (Lys-Glu) in research-grade lyophilized format with COA, HPLC, and mass spectrometry data per lot. Pricing, MOQ, and label coordination are reviewed during account intake.



